Construction projects operate under constant pressure—tight timelines, rising material costs, workforce shortages, and increasing safety and compliance requirements. Despite this, many organizations still rely on fragmented systems and reactive decision-making, identifying risks only after delays, cost overruns, or site incidents occur.

AI-Driven Demand Forecasting in Retail

Digital therapeutics are no longer a futuristic concept; they’re actively transforming how patients receive, monitor, and manage care. As the MedTech industry evolves, DTx solutions have become central to personalized, preventive, and data-driven healthcare. At Innominds, we work with leading global MedTech innovators to design and engineer next-generation digital therapeutic platforms that

As healthcare devices become more intelligent and more connected, Edge AI is emerging as a transformative force across the MedTech landscape. Edge AI brings intelligence directly to the device, enabling medical systems to analyze data locally, make real-time decisions, and operate effectively even without continuous cloud connectivity. For device manufacturers, this shift represents more than a

The healthcare industry is undergoing a profound shift — moving beyond episodic treatment toward continuous, intelligent, and empathetic patient journeys. As Digital Therapeutics (DTx) evolve into data-driven care ecosystems, Generative AI (Gen AI) is redefining how patients experience therapy, adhere to treatment, and achieve meaningful health outcomes.

As enterprises accelerate their digital transformation, cloud adoption has become central to business agility and innovation. However, managing cloud costs at scale remains a persistent challenge. Despite using native cost management tools, organizations often face budget overruns, billing complexities, and limited visibility across multiple cloud environments.

Digital health is entering a new era — one where Generative AI (GenAI) drives deeper and more human-centered patient engagement. As Digital Therapeutics (DTx) redefine care delivery through evidence-based software interventions, their success increasingly depends on one factor — sustained patient engagement and adherence. That’s where GenAI transforms the equation — making digital health

The construction industry is at a tipping point. Large projects are becoming increasingly complex, labor shortages are intensifying, and pressure to deliver on time and within budget has never been higher. Studies show that more than 70% of large construction projects exceed timelines and costs, while safety incidents and compliance lapses continue to challenge even the best-run firms.

Digital Therapeutics (DTx) are revolutionizing the way patients manage chronic conditions, mental health disorders, and lifestyle diseases. Yet, while most DTx solutions succeed in creating awareness, few manage to sustain adherence — the true measure of both clinical and commercial success.

In regulated industries like MedTech, compliance is non-negotiable. It safeguards patient safety, data integrity, and market trust. But here’s the hidden truth: the very systems designed to protect innovation are often slowing it down.